Related Experiment Video
Updated: Jun 23, 2025

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023
Cancer: A Multifaceted Enemy and the Precision Oncology Response
1Institute of Biomedical Technologies, National Research Council (CNR), Area della Ricerca di Pisa, 56124 Pisa, Italy.
Abstract:
Cancer heterogeneity presents a major obstacle in clinical practice that grants tumor cells remarkable levels of resilience, adaptability, and invasiveness [...].
Insights
Cancer heterogeneity, the diversity of tumor cells, makes cancer resilient and invasive. Understanding this diversity is key to overcoming treatment challenges and improving patient outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Genomics
Background:
- Cancer heterogeneity poses a significant challenge in clinical oncology.
- Tumor cell diversity contributes to treatment resistance, adaptability, and invasiveness.
Discussion:
- Addressing cancer heterogeneity is crucial for developing effective therapeutic strategies.
- Research into the mechanisms driving tumor cell diversity is ongoing.
Key Insights:
- Cancer heterogeneity impacts treatment efficacy and patient prognosis.
- Understanding the molecular basis of tumor diversity is essential for targeted therapies.
Outlook:
- Future research will focus on personalized medicine approaches to combat cancer heterogeneity.
- Novel therapeutic interventions targeting specific tumor cell populations are under development.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

